Caprion Pharmaceuticals


Public lists: Pharma Startups (4734)

Caprion's leading and proteomics discovery technologies - CellCarta - enable the discovery of targets for therapeutics development and the identification of protein biomarkers that can reduce risk and enhance clinical development productivity and decision making in Pharmaceutical research. In March 2007, Caprion Pharmaceuticals merged with Ecopia BioSciences to form Thallion Pharmaceuticals.

Caprion's leading and proteomics discovery technologies - CellCarta - enable the discovery of targets for therapeutics development and the identification of protein biomarkers that can reduce risk and enhance clinical development productivity and de...Show all

Company (Merged)

Phone: 514-940-3600

Fax:

7150 Alexander-Fleming
Montreal, H4S 2C8
Quebec, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Caprion Pharmaceuticals $1.9M Mar 19, 2007
Five Prime Therapeutics $178.4M Sep 18, 2013
Stheno Corporation $2.3M May 11, 2007
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Caprion Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)